Drug profile · INN
certolizumab pegol
CIMZIA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
certolizumab pegol (CIMZIA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN certolizumab pegol
Brand CIMZIA
Route INJECTION
Formulation INJECTABLE
ATC code L04AB05
Frequently asked questions
What is certolizumab pegol?
certolizumab pegol (CIMZIA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for certolizumab pegol?
CIMZIA is a marketed brand name for certolizumab pegol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of certolizumab pegol?
certolizumab pegol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.